Drug Factory Microbiome: Top Three Actionable Challenges and Prospects
Author(s) -
Mona T. Kashef,
Ramy K. Aziz
Publication year - 2020
Publication title -
omics a journal of integrative biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.811
H-Index - 58
eISSN - 1557-8100
pISSN - 1536-2310
DOI - 10.1089/omi.2019.0202
Subject(s) - microbiome , pharmacy , factory (object oriented programming) , medicine , library science , biology , bioinformatics , family medicine , computer science , programming language
To the Editor: Microbiome research is advancing on diverse and multiple frontiers. An interesting and emerging arena is the microbiome of built environments and how it affects human health and lifestyle. Recently, drug factories were studied as interesting built environments in which humans, machines, and pharmaceutical ingredients interact, in a quite clean environment (which ranges from fully aseptic, in case of parenteral products, to monitored clean areas, for other types of formulations). However, studies addressing microbiomes of drug factories, clean rooms, or production lines remain scarce. Looking forward to 2020, we highlight three actionable emerging challenges in drug factory microbiome research, which might transform to prospects for clinical or discovery science innovation if they are adequately and promptly addressed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom